BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15781198)

  • 1. Management and outcome of neonatal-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life.
    Ensenauer R; Tuchman M; El-Youssef M; Kotagal S; Ishitani MB; Matern D; Babovic-Vuksanovic D
    Mol Genet Metab; 2005 Apr; 84(4):363-6. PubMed ID: 15781198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency.
    McBride KL; Miller G; Carter S; Karpen S; Goss J; Lee B
    Pediatrics; 2004 Oct; 114(4):e523-6. PubMed ID: 15466081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency.
    Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K
    Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.
    Cunningham SC; Kok CY; Spinoulas A; Carpenter KH; Alexander IE
    Gene Ther; 2013 Dec; 20(12):1184-7. PubMed ID: 24108150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ornithine transcarbamylase deficiency in pregnancy.
    Mendez-Figueroa H; Lamance K; Sutton VR; Aagaard-Tillery K; Van den Veyver I
    Am J Perinatol; 2010 Nov; 27(10):775-84. PubMed ID: 20458665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy.
    Hasegawa T; Tzakis AG; Todo S; Reyes J; Nour B; Finegold DN; Starzl TE
    J Pediatr Surg; 1995 Jun; 30(6):863-5. PubMed ID: 7666324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia management protocol for liver transplantation as treatment for ornithine transcarbamylase deficiency.
    Baba C; Yukimasa S; Yasuno R; Ichiyanagi H; Ninagawa J; Kasuya S; Kasahara M; Horikawa R; Nagasaka Y; Suzuki Y
    Paediatr Anaesth; 2023 Aug; 33(8):620-630. PubMed ID: 37401903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal neonatal hyperammonemia in severe ornithine transcarbamylase (OTC) deficiency compounded by large hepatic portosystemic shunt.
    Beard L; Wymore E; Fenton L; Coughlin CR; Weisfeld-Adams JD
    J Inherit Metab Dis; 2017 Jan; 40(1):159-160. PubMed ID: 27832417
    [No Abstract]   [Full Text] [Related]  

  • 11. Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency.
    Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Egami S; Sakamoto K; Murayama K; Hakamada K; Yasuda Y; Mizuta K
    Pediatr Transplant; 2012 Sep; 16(6):E196-200. PubMed ID: 22583334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency.
    Puppi J; Tan N; Mitry RR; Hughes RD; Lehec S; Mieli-Vergani G; Karani J; Champion MP; Heaton N; Mohamed R; Dhawan A
    Am J Transplant; 2008 Feb; 8(2):452-7. PubMed ID: 18211511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects.
    Meyburg J; Das AM; Hoerster F; Lindner M; Kriegbaum H; Engelmann G; Schmidt J; Ott M; Pettenazzo A; Luecke T; Bertram H; Hoffmann GF; Burlina A
    Transplantation; 2009 Mar; 87(5):636-41. PubMed ID: 19295306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.
    Horslen SP; McCowan TC; Goertzen TC; Warkentin PI; Cai HB; Strom SC; Fox IJ
    Pediatrics; 2003 Jun; 111(6 Pt 1):1262-7. PubMed ID: 12777539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.
    Busuttil AA; Goss JA; Seu P; Dulkanchainun TS; Yanni GS; McDiarmid SV; Busuttil RW
    Liver Transpl Surg; 1998 Sep; 4(5):350-4. PubMed ID: 9724471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
    Cunningham SC; Kok CY; Dane AP; Carpenter K; Kizana E; Kuchel PW; Alexander IE
    Mol Ther; 2011 May; 19(5):854-9. PubMed ID: 21386824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of an acquired urea cycle disorder post liver transplantation.
    Ghabril M; Nguyen J; Kramer D; Genco T; Mai M; Rosser BG
    Liver Transpl; 2007 Dec; 13(12):1714-6. PubMed ID: 18044746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative Treatment of Ornithine Transcarbamylase Deficiency With a Liver Transplant: A Case Report.
    Shamsaeefar A; Nikeghbalian S; Dehghani SM; Kazemi K; Motazedian N; Geramizadeh B; Malekhosseini SA
    Exp Clin Transplant; 2019 Feb; 17(1):119-120. PubMed ID: 27447480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency.
    Plöchl W; Plöchl E; Pokorny H; Kozek-Langenecker S; Zacherl J; Stöckler-Ipsiroglu S; Wermuth B; Spiss CK; Mühlbacher F
    Transpl Int; 2001 Jun; 14(3):196-201. PubMed ID: 11499911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonate-onset ornithine transcarbamylase deficiency].
    Gao RW; Ba Y; Zhang R; Cao Y; Yang L; Wu BB; Zhou WH; Zhou JG
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):431-435. PubMed ID: 37073851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.